IDiyas

For the Inventor, By the Inventor

Birmingham, AL, United States of America

John A Secrist, Iii

USPTO Granted Patents = 39 

 

Average Co-Inventor Count = 3.5

ph-index = 15

Forward Citations = 1,269(Granted Patents)


Company Filing History:

goldMedal30 out of 203 
 
Southern Research Institute
 patents
silverMedal5 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal5 out of 5 
 
Biocryst, Inc.
 patents
4. 3 out of 81 
 
Biocryst Pharmaceuticals, Inc.
 patents
5. 2 out of 580 
 
The Uab Research Foundation
 patents
6. 1 out of 1,215 
 
The United States of America As Represented by the Department of Health
 patents
7. 1 out of 1,521 
 
Cornell Research Foundation Inc.
 patents
8. 1 out of 6 
 
Cornell Center for Technology, Enterprise and Commercialization
 patents
9. 1 out of 1,360 
 
Cornell University
 patents
10. 1 out of 290 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents
11. 1 out of 1,217 
 
The Penn State Research Foundation
 patents
where one patent can have more than one assignee

Years Active: 1988-2016

Loading Chart...
Loading Chart...
39 patents (USPTO):
1. 9433621 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2016-09-06),
2. 8859589 - Use of 4'-thio-2′-deoxynucleosides as anti orthopoxvirus agents (2014-10-14),
3. 8715638 - Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2014-05-06),
4. 8697694 - Substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2014-04-15),
5. 8637485 - 5',-substituted adenosynes preparation thereof and use as inhibitors of S-adenosylmethionine decarboxylase (2014-01-28),
6. 8541434 - Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2013-09-24),
7. 8470834 - AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections (2013-06-25),
8. 8178510 - Preparation of thioarabinofuranosyl compounds and use thereof (2012-05-15),
9. 7838508 - 4'-thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof (2010-11-23),
10. 7691820 - Preparation of thioarabinofuranosyl compounds and use thereof (2010-04-06),
11. 7488598 - Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof (2009-02-10),
12. 7470784 - [object Object] (2008-12-30),
13. 7148223 - 4'-thio-L-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof (2006-12-12),
14. 7138385 - Thioarabinofuranosyl compounds and use thereof (2006-11-21),
15. 7037718 - Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof (2006-05-02),

Title: John A Secrist, III - Pioneering Inventor from Birmingham

Introduction: John A Secrist, III is a renowned inventor hailing from Birmingham, Alabama. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: John A Secrist, III holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment.

Career Highlights: Throughout his illustrious career, John A Secrist, III has been recognized for his groundbreaking inventions that have revolutionized industries. His dedication to pushing the boundaries of technology has led to the development of cutting-edge solutions that improve the quality of life for many.

Collaborations: John A Secrist, III has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has resulted in successful partnerships that have propelled his innovations forward.

Conclusion: John A Secrist, III's innovative spirit and commitment to excellence continue to inspire the next generation of inventors. His impact on the world of technology is undeniable, and his legacy as a pioneering inventor from Birmingham, AL, will endure for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…